SPONSOR
Jinling Hospital, China
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)Metabolic Dysfunction-associated Steatotic Liver DiseaseHepatic SteatosisNon-alcoholic Fatty Liver DiseasesShort Bowel Syndrome (SBS)Intestinal FailureNephrectomyRenal Cell CancerAKI - Acute Kidney Injury
Jinling Hospital, China is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Renal Cell Carcinoma (RCC), Metastatic Renal Cell Carcinoma (mRCC), Metabolic Dysfunction-associated Steatotic Liver Disease, Hepatic Steatosis.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jinling Hospital, China
How many clinical trials has Jinling Hospital, China sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Jinling Hospital, China, of which 5 are actively recruiting participants. These trials cover conditions including Renal Cell Carcinoma (RCC), Metastatic Renal Cell Carcinoma (mRCC), Metabolic Dysfunction-associated Steatotic Liver Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jinling Hospital, China research focus on?
Jinling Hospital, China clinical trials span Renal Cell Carcinoma (RCC), Metastatic Renal Cell Carcinoma (mRCC), Metabolic Dysfunction-associated Steatotic Liver Disease, Hepatic Steatosis, Non-alcoholic Fatty Liver Diseases, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jinling Hospital, China clinical trial?
To participate in a Jinling Hospital, China trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jinling Hospital, China trials with current recruitment status updated daily.
Clinical Trials by Jinling Hospital, China
NCT07175480 Phase 2
Recruiting
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
Renal Cell Carcinoma (RCC)
NCT06619808
Recruiting
Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases
Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07297238
Recruiting
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
Short Bowel Syndrome (SBS)
NCT07294859
Recruiting
Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
Nephrectomy
NCT05917106
Recruiting
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology